Researchers from Lanzhou University and Southern Medical University (China) have presented the discovery of a structurally distinct pyrimidine-based chemotype for the inhibition of KRAS G12C.
Relatively few specific anti-coronavirus disease 2019 (COVID-19) treatments exist. Until recently, hospitals were forced to either treat the symptoms using mechanical ventilation and oxygen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results